###begin article-title 0
Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling
###end article-title 0
###begin p 1
Elena V. Efimova and Hua Liang contributed equally to this work.
###end p 1
###begin p 2
This is an open access article distributed under the , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin title 3
Purpose
###end title 3
###begin p 4
To determine the mechanisms of Signal Transducer and Activator of Transcription 1 (Stat1)-associated radioresistance developed by nu61 tumour selected in vivo by fractionated irradiation of the parental radiosensitive tumour SCC61.
###end p 4
###begin title 5
Materials and methods
###end title 5
###begin p 6
Radioresistence of nu61 and SCC61 in vitro was measured by clonogenic assay. Apoptotic response of nu61 and SCC61 cells to genotoxic stress was examined using caspase-based apoptotic assays. Co-cultivation of carboxyfluorescein diacetate, succinimidyl ester (CFDE-SE)-labeled nu61 with un-labeled SCC61 was performed at 1:1 ratio. Production of interleukin-6, interleukin-8 and soluble receptor of interleukin 6 (IL6, IL8 and sIL6R) was measured using Enzyme-Linked Immunosorbent Assay (ELISA).
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
Radioresistant nu61 was also resistant to interferon-gamma (IFNgamma) and the death ligands of tumour necrosis factor alpha receptor (TNFR) family when compared to SCC61. This combined resistance is due to an impaired apoptotic response in nu61. Relative to SCC61, nu61 produced more IL6, IL8 and sIL6R. Using Stat1 knock-downs we demonstrated that IL6 and IL8 production is Stat1-dependent. Treatment with neutralising antibodies to IL6 and IL8, but not to either cytokine alone sensitised nu61 to genotoxic stress induced apoptosis.
###end p 8
###begin title 9
Conclusion
###end title 9
###begin p 10
Nu61, which over-expresses Stat1 pathway, is deficient in apoptotic response to ionising radiation and cytotoxic ligands. This resistance to apoptosis is associated with Stat1-dependent production of IL6 and IL8 and suppression of 8, 9 and 3.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 142 164 142 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">Lee and Bernstein 1993</xref>
###xml 166 185 166 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48">Tyrsina et al. 2005</xref>
###xml 187 204 187 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">Otero et al. 2006</xref>
###xml 436 456 436 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">Khodarev et al. 2004</xref>
###xml 868 888 868 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">Amundson et al. 2004</xref>
###xml 890 910 890 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">Khodarev et al. 2007</xref>
###xml 1338 1358 1338 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">Khodarev et al. 2007</xref>
###xml 1636 1656 1636 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">Khodarev et al. 2004</xref>
###xml 1658 1675 1658 1675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">Brown et al. 2004</xref>
###xml 1677 1700 1677 1700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">Lehrnbecher et al. 2008</xref>
###xml 275 280 <span type="species:ncbi:9606">human</span>
Tumour cells may acquire radioresistance using multiple pathways including those which are induced/altered by ionising radiation (IR) itself (Lee and Bernstein 1993, Tyrsina et al. 2005, Otero et al. 2006). To investigate IR-induced tumour radio-resistance, a radiosensitive human squamous cell carcinoma tumour, SCC61, was passed and irradiated in vivo. Radioresistant tumours were selected and a tumour cell line, nu61, was isolated (Khodarev et al. 2004). Analysis of the differences in gene expression between cells from differentially selected tumours demonstrated up-regulation of the genes in the Signal Transducer and Activator of Transcription 1 (Stat1) signalling pathway in radioresistant nu61 tumours compared with radiosensitive SCC61 tumours. Recently we and others reported that IR up-regulates Stat1 and a Stat1-dependent pathway in vitro and in vivo (Amundson et al. 2004, Khodarev et al. 2007) and tumour cells resistant to radiation are also resistant to interferon. These results suggested cross-talk between pathways induced by interferons (IFN) and IR. We hypothesised that the development of resistance to the constitutively expressed Stat1 pathway in tumour cells is associated with suppression of the Stat1-dependent apoptotic pathways or/and clonal selection of the cells resistant to Stat1-dependent apoptosis (Khodarev et al. 2007). Next, taking into account that the Stat1 pathway, at least in the context of IFN-signalling, leads to the induction of multiple cytokines, we hypothesised that some Stat1-dependent, pro-survival genes might encode soluble factors secreted by the Stat1 over-expressing cells (Khodarev et al. 2004, Brown et al. 2004, Lehrnbecher et al. 2008). Here we report that indeed apoptotic response in nu61 is impaired resulting in suppression of caspases 3, 7, 8 and 9. This impaired response leads to the resistance not only to IFNs and IR but also to death ligands of tumour necrosis factor alpha receptor (TNFR) superfamily. We also report that nu61 differentially express interleukin-6, interleukin-8 and soluble receptor of interleukin 6 (IL6, IL8 and sIL6R) and this expression is Stat1-dependent. Formation of IL6-IL8-dependent autocrine loops plays a role in nu61 resistance to IR and cytotoxic cytokines. Combined suppression of IL6 and IL8 signalling by neutralising antibodies led to sensitisation of nu61 to genotoxic stress. These data suggest IL6 and IL8 as potential targets for tumour radiosensitisation.
###end p 12
###begin title 13
Materials and methods
###end title 13
###begin title 14
Cell lines
###end title 14
###begin p 15
###xml 420 440 420 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">Khodarev et al. 2007</xref>
###xml 125 131 <span type="species:ncbi:9913">bovine</span>
SCC61 and nu61 were cultured in Dulbecco modified Eagle's Media (DMEM-F12) (Invitrogen, CA, USA) supplemented with 20% fetal bovine serum, 2 mM L-glutamine, 100 U/ml penicillin/streptomycin. Cells were maintained at 378C in a humidified chamber with 7% CO2. Stat1 knockdowns and control retroviral vector L4 (Clontech, Palo Alto, CA, USA)-transfected cell lines of SCC61 and nu61 were generated as previously described (Khodarev et al. 2007) and cultured as the parental cell lines. Control vector (CV)-transfected nu61 was named N1L4 (nu61-L4) and CV-transfected SCC61-S1L4 (SCC61-L4). The corresponding cell lines with Stat1 knock-downs were named as NKD and SKD, respectively.
###end p 15
###begin title 16
Reagents
###end title 16
###begin p 17
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 143 148 <span type="species:ncbi:9606">human</span>
###xml 264 269 <span type="species:ncbi:9606">human</span>
Recombinant human tumour necrosis factor alpha (TNFalpha) and propidium iodide (PI) were purchased from Sigma (St Louis, MO, USA). Recombinant human TNF-related apoptosis inducing ligand (TRAIL) was purchased from Peprotech, Inc (Rocky Hill, NJ, USA). Recombinant human interferon gamma (IFN-gamma), interleukin-6 (IL6) and interleukin-8 (IL8) neutralising antibodies were purchased from R and D Systems (Minneapolis, MN, USA). Anti-Fas (tumour necrosis factor receptor superfamily, member 6; TNFRSF6) CH11 antibody was purchased from Upstate (Charlottesville, VA, USA). Vybrant CFDA-SE (carboxyfluorescein diacetate, succinimi-dylester) cell tracer kit, Vybrant fluoromethyl ketone (FAM) caspase-8 assay kit, Vybrant FAM caspase-3 and -7 assay kits were purchased from Invitrogen (Carlsbad, CA, USA). The caspase-9 detection kit was purchased from Cell Technology, Inc. (Mountain View, CA, USA). The active caspase-3 phycoerythrin (PE) conjugated monoclonal antibody was from BD Pharmigen (San Jose, CA, USA).
###end p 17
###begin title 18
Irradiation
###end title 18
###begin p 19
Cells were irradiated using a GE Maxitron Generator operating at 250 kV, 26 mA at a dose rate of 1.18 Gy/min. Samples were collected after irradiation as described in results.
###end p 19
###begin title 20
Clonogenic survival assay
###end title 20
###begin p 21
###xml 57 76 57 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">Salloum et al. 2000</xref>
###xml 108 137 108 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">Weichselbaum and Beckett 1987</xref>
###xml 139 148 139 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">Hall 1988</xref>
Clonogenic survival assay was performed as described in (Salloum et al. 2000) and analysed as described in (Weichselbaum and Beckett 1987, Hall 1988).
###end p 21
###begin title 22
Flow cytometry
###end title 22
###begin p 23
Data were collected on a fluorescence-activated cell sorting FACScan instrument using CellQuest Software (Becton-Dickinson, Franklin Lakes, NJ, USA). At least 10000 events were collected for each sample. FlowJo Software (FlowJo, LLC, Ashland, OR, USA) was used for data analysis. Experiments were repeated 3-4 times per cell line with consistent results.
###end p 23
###begin title 24
Apoptosis/cell death detection assays
###end title 24
###begin p 25
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 185 192 181 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results</italic>
Cells were plated in six-well plates at 1 x 105 cells/well in growth medium. After 24 h, cells were left untreated or treated with radiation, IFNgamma in designated concentrations (see Results), 10 ng/ml TNFalpha, TRAIL, or Fas-activating antibody CH11. 24 or 48 h later cells were harvested, washed in cold phosphate buffer saline (PBS) and stained for 5 min in 1 mug/ml propidium iodide (Sigma, St Louis, MO, USA), followed by FACS analysis, to detect late apoptotic or necrotic cells. Cells with active caspase-3 were detected by analysing the fluorescein isothiocyanate (FITC)-positive population using Vybrant FAM caspase-3 kit (Invitrogen) according to the manufacturer's protocol. For measurement of activation of caspases 8, 9 and 3/7 in cell cultures we used luminescent-based Caspase-Glo(R) assays, provided by Promega (Madison, WI, USA).
###end p 25
###begin title 26
Co-cultivation of nu61 and SCC61
###end title 26
###begin p 27
In experiments where the cells are co-cultured in physical contact with each other, nu61 were labeled with CFDA-SE and placed in co-culture with unlabeled SCC61 in a 1:1 ratio. Treatment with 3 Gy IR, 50 ng/ml IFNgamma and 10 ng/ml TNFalpha was begun 24 h later and cells harvested for flow cytometry 48 h later.
###end p 27
###begin title 28
Measurement of IL6, IL8 and sIL6R secretion in CV-transfected and Stat1 knock-downed SCC61 and nu61 cell lines
###end title 28
###begin p 29
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 437 457 437 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">Khodarev et al. 2001</xref>
S1L4, N1L4, SKD and NKD were plated at concentrations of 0.3-0.5 x 106 cells/well in six-well plates with 2.0 ml of growth media. Some 18-24 h later cells were irradiated, incubated for an additional 48 h and samples of conditioned media were collected for ELISA analysis. In preliminary experiments, we compared irradiation at 3 and 6 Gy and found that in these conditions 3 Gy led to a more pronounced induction of IL6, IL8 and sIL6R (Khodarev et al. 2001). Therefore this dose (3 Gy) was used in all subsequent experiments. Each cell line was plated in three independent wells. ELISA kits were obtained from R & D Systems (Minneapolis, MN, USA) and concentrations of IL6, IL8 and sIL6R were determined according to manufacturer's instructions.
###end p 29
###begin title 30
Neutralisating antibodies against IL6 and IL8
###end title 30
###begin p 31
To determine the effect of neutralising antibodies (N-Ab) against IL6 and IL8 on cell survival and IR-resistance, 30,000 nu61 cells/well were plated on 96-well plates. 24 hours later cells were treated with N-Ab against IL-6 (1 mug/ml, R & D Systems), IL8 (20 mug/ml, R & D Systems), or both, 4 h before treatment with IR or IFNgamma (50 ng/ml). 24-48 h after treatment, caspase 3 and 7 activation were determined using Caspase-Glo(R) assay (Promega) and by FACS analysis after cell staining with an antibody specific for the active form of caspase-3.
###end p 31
###begin title 32
Statistical analysis
###end title 32
###begin p 33
###xml 166 167 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 186 187 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
All experiments were performed at least three times. Quantitative data are presented as mean +/- SE. Significance of difference was estimated by Student's two-tailed t-test with cut-off p </= 0.05.
###end p 33
###begin title 34
Results
###end title 34
###begin title 35
Nu61 are more radioresistant in vitro compared to SCC61 based on clonogenic survival assay
###end title 35
###begin p 36
###xml 202 222 202 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">Khodarev et al. 2004</xref>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">2007</xref>
###xml 413 430 413 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">Quiet et al. 1991</xref>
###xml 520 528 520 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 683 692 683 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">Hall 1988</xref>
###xml 784 813 784 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">Weichselbaum and Beckett 1987</xref>
###xml 851 852 851 852 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 940 941 938 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 973 974 971 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1123 1124 1115 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1158 1159 1150 1151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1288 1289 1276 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1311 1312 1299 1300 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1383 1412 1371 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">Weichselbaum and Beckett 1987</xref>
###xml 1414 1430 1402 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50">Wang et al. 2008</xref>
###xml 1580 1597 1568 1585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">Blenn et al. 2006</xref>
###xml 1599 1615 1587 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">Hara et al. 2008</xref>
In our previous reports we demonstrated that the nu61 tumour, selected from the SCC61 tumour by in vivo fractionated irradiation, is more radioresistant based on in vivo assays and overexpresses Stat1 (Khodarev et al. 2004, 2007). In the current experiments we directly compared in vitro clonogenic survival of SCC61 and nu61. It has been shown previously that the parental SCC61 has very low clonogenic ability (Quiet et al. 1991). We therefore used a relatively low range of doses (between 0 and 5 Gy). As is shown in Figure 1, the major difference between the two cell lines was observed between 0 and 2 Gy as a pronounced shoulder in nu61. We used a biphasic model described in (Hall 1988) and previously used by us for correlation of tumour radioresistance in vitro and in vivo (Weichselbaum and Beckett 1987). We found that between 2 and 5 Gy, D0 values for SCC61 and nu61 were 0.66+/-0.03 and 0.60+/-0.07, respectively (mean +/- SE, p > 0.05). Extrapolation number (n) was higher for nu61 compared to SCC61 (3.46 +/- 2.36 and 1.43 +/- 0.14 respectively; mean +/- SE) but these differences were also not significant (p > 0.05). However, estimation of D1 in the dose range between 0 and 2 Gy revealed a significant difference between nu61 and SCC61 (2.75 +/- 0.03 and 0.99 +/- 0.03; p < 0.05). The larger D1 value in nu61 may be attributed to increased sublethal damage repair (Weichselbaum and Beckett 1987, Wang et al. 2008). Literature indicates that sublethal damage repair is connected with increased resistance to genotoxic stress associated with suppressed apoptosis (Blenn et al. 2006, Hara et al. 2008).
###end p 36
###begin p 37
###xml 175 182 175 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 219 226 219 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 237 244 237 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results</italic>
Clonogenic survival of nu61 (black squares) and SCC61 (white diamonds). Cells were plated at P60 (three dishes per dose) and 18 hours after plating irradiated as indicated in Methods. Data were analysed as described in Methods (see also Results for details). Experiments were repeated three times. Shown are mean values; error bars-standard error (SE).
###end p 37
###begin title 38
Nu61 demonstrates impaired apoptotic response to ionising radiation and interferons
###end title 38
###begin p 39
###xml 432 439 428 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 540 549 536 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 688 697 680 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 799 806 791 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 936 937 924 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
To test the hypothesis that the suppression of cell death in nu61 following IR and IFNgamma is due to the suppression of the apoptotic response located downstream from Stat1, we analysed cell death and the apoptotic response in nu61 and SCC61 cell lines. We used PI staining at 48 h as an index of total cell death, and measured apoptosis by flow cytometry for detection of cells that express the proximal caspase-3 as described in Methods. All experiments were repeated at least three times, and representative data are shown. As shown in Figure 2A, ionising radiation (6 Gy) induced 26.2% (23.3 +/- 8.3%) PI positive cells in SCC61 and 13.3% (10.33 +/- 3.4%) PI positive cells in nu61. Figure 2B shows the same trend for the post-IR accumulation of caspase-3-positive cells in SCC61 and nu61 (see Methods). 29.6% (27.5 +/- 2.9%) of caspase-3-positive cells accumulated in SCC61 48 hours post-IR and only 10.3% (9.8 +/- 1.5%) in nu61 (p = 0.005). These data show that the differences in post-irradiation survival between nu61 and SCC61 are mediated by caspase-3 mediated apoptosis which is suppressed in nu61.
###end p 39
###begin p 40
Down-regulation of caspase-3 activation in nu61 results in decreased cell death in response to treatment with IR and IFNgamma. 48 hours after a single dose of 6 Gy IR, or 50 ng/ml of IFNgamma nu61 and SCC61 cells were either stained with PI (panel A) as a measure of cell death or active caspase-3 (panel B) to measure apoptosis. Nu61 cells demonstrate both reduced total cell death (panel A) and apoptosis (panel B) compared to SCC61 in response to IR and IFNgamma (see text for details). Shown are representative data of three independent experiments.
###end p 40
###begin p 41
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 217 218 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 238 247 226 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 332 341 320 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 489 490 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 577 578 557 558 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Figure 2 shows also the response of SCC61 and nu61 to IFNgamma (50 ng/ml). Forty-eight hours following 50 ng/ml IFNgamma, 64.8% (61 +/- 5.8%) of PI positive cells were detected in SCC61 and only 12.2% (13.8 +/- 1.3%; p < 0.0001) in nu61 (Figure 2A). Accumulation of caspase-3-positive cells was simultaneous with PI-positive cells (Figure 2B). 48 hours post IFNgamma treatment 20.4% (19.8 +/- 2.1%) of caspase-3-positive cells were detected in SCC61 and only 6.93% (7.3 +/- 1.5%) in nu61 (p = 0.03). Pretreatment of both cell lines with the caspase-inhibitor Z-Val-Ala-Asp (OCH3)-fluoromethylketone (Z-VAD-FMK) abolished apoptotic response to both IR and IFNgamma (data not shown). We concluded from these experiments that interferon and radiation-induced cell death can be accounted for by activation of caspase-3-mediated apoptosis, and the decrease in the apoptotic response, at least in part, accounts for the suppressed sensitivity to IFN and IR in nu61 relative to SCC61.
###end p 41
###begin title 42
Resistance to IR and interferons correlates with the resistance to death ligands
###end title 42
###begin p 43
###xml 318 326 314 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
###xml 470 471 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 499 500 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 663 671 655 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">Kim 2005</xref>
###xml 673 695 665 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">Fulda and Debatin 2006</xref>
We next tested the hypothesis that resistance to genotoxic stress and interferons correlates with the resistance to death ligands of TNFR superfamily. We studied the cytotoxic effects of TNFalpha, CH11 (FAS-activating antibody) and TRAIL (TNF-related apoptosis inducing ligand) in nu61 and SCC61 cells. As is shown in Figure 3, each ligand, as well as irradiation and IFNgamma, led to significant apoptotic death in SCC61 compared to nu61 (significance was estimated by t-test with cut-off value of p < 0.05). Both proximal caspases (CASP8 and CASP9) were activated in SCC61 compared with nu61, indicating that both intrinsic and extrinsic pathways of apoptosis (Kim 2005, Fulda and Debatin 2006) are functional in the parental SCC61 cell line, but are suppressed in nu61. Effector caspases 3/7 were also suppressed in nu61 compared to SCC61 confirming that the cell death detected in our experiments is connected with apoptosis. Similar data were detected in flow cytometry experiments (data not shown). These data show that overall cell death induced by the TNFR family ligands, IFNgamma and IR was mediated by apoptosis in both cell lines and the resistance of nu61 to IR, IFNs and the TNFR family ligands is due to the suppression of apoptotic caspases 3, 8 and 9.
###end p 43
###begin p 44
###xml 612 619 602 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 719 720 709 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 727 728 717 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Proximal and effector caspases activation is suppressed in nu61 compared to SCC61 in response to genotoxic stress and death ligands of the TNF superfamily. Activation of the proximal caspases of the extrinsic (panel B) and intrinsic (panel C) apoptotic pathways, as well as the effector caspases-3 and -7 (panel A) common to both pathways were measured after treatment with 10 ng/ml TNFalpha, 25 ng/ml CH11 (Fas-activating antibody), 100 ng/ml TRAIL, 6 Gy IR or 50 ng/ml IFNgamma at 24 h after treatment for caspases-8 and -9 and 48 h for caspases-3 and -7. For all measurements we used Caspase-Glo(R) kits (see Methods). Black bars represent SCC61, white bars represent nu61. Error bars represent standard deviations (n = 3). p values are less than 0.05 for all graphs, representing significant differences between SCC61 and nu61.
###end p 44
###begin title 45
Co-cultivation of nu61 with SCC61 partially protects SCC61 from apoptosis
###end title 45
###begin p 46
###xml 183 190 183 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 517 526 509 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 827 836 819 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 1043 1044 1031 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1167 1168 1151 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1182 1191 1166 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
In the next set of experiments, we co-cultivated SCC61 with nu61 to see if SCC61 could be rescued by the presence of proteins secreted by nu61. Nu61 cells were labeled with CFDA (see Methods) mixed with unlabeled SCC61 at a 1:1 ratio, and 24 h later, treated with IR (3 Gy), IFNgamma (50 ng/ml) or TNFalpha (10 ng/ml). 48 h after treatment, cell death was determined by PI staining using flow cytometry. Control experiments were run in which monocultures of the same cell lines were subjected to the same treatments. Figure 4A shows that in the co-culture with nu61 SCC61 is more sensitive to cytotoxic treatments than nu61, consistent with our previous data. However, comparing the relative amount of cell death of SCC61 in monoculture with SCC61 in co-culture, we found that co-culture protects SCC61 from cytotoxic stimuli. Figure 4B show that treatment by TNFalpha did not lead to significant difference between SCC61 cultivated in mono-culture or co-culture with nu61. However, treatment by IR led to the significant 5.5-fold protection (p = 0.023) and treatment by 50 ng/ml of IFNgamma led to 1.6-fold protection of SCC61 in co-culture relative to monoculture (p = 0.026: see Figure 4B). These data suggested that nu61 can produce some secreted factors, which provide protection of the parental SCC61 cells from the cytotoxic insult.
###end p 46
###begin p 47
###xml 324 331 324 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
Interaction of nu61 and SCC61 cells partially protects SCC61 from cell death and is associated with differential secretion of IL6, sIL6R and IL8. Nu61 cells were labeled with CFDA-SE (upper quadrants in panel A) to distinguish them from SCC61 (lower quadrants of panel A). Cells were co-cultured and treated as described in Methods. Although nu61 do not completely rescue SCC61 from cytotoxic treatments (panel A), SCC61 cells in co-culture compared with SCC61 cells in monoculture (panel B) are more resistant to cell death. Shown on panel B are mean values of three independent experiments +/- SE.
###end p 47
###begin title 48
Identification of the pro-survival factors secreted by nu61
###end title 48
###begin p 49
###xml 119 137 119 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">Levina et al. 2008</xref>
###xml 390 397 390 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 751 771 751 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">Khodarev et al. 2007</xref>
###xml 993 1013 993 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">Khodarev et al. 2007</xref>
###xml 1199 1206 1199 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 1209 1220 1209 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A&#8211;C</xref>
###xml 1429 1430 1429 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1499 1500 1499 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1591 1592 1591 1592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
To identify pro-growth/pro-survival factors produced by nu61, we performed pilot experiments using Luminex technology (Levina et al. 2008). Out of 35 cytokines tested we found that, IL8 and soluble IL6 receptor (sIL6R) were differentially produced by nu61 relative to SCC61 (data not shown). To investigate the relative expression of IL6, IL8 and sIL6R in nu61 and SCC61 we used ELISA (see Methods). Since we were interested in the potential relationships between Stat1 expression and the expression of IL6, IL8 and sIL6R, we used stable Stat1 knock-downs and CV-transfected cell lines of SCC61 and nu61. We showed previously that stable Stat1 knock-down by retroviral-based shRNA led to 2.5-fold suppression of Stat1 protein in NKD relative to N1L4 (Khodarev et al. 2007). Furthermore we demonstrated that this knock-down leads to significant 1.9-fold radiosensitisation of N1L4 in vivo. These data indicated that some prosurvival/radioprotective pathways may operate down-stream from Stat1 (Khodarev et al. 2007). We therefore suggested that IL6-IL8 signalling may participate in these pathways. First we compared production of IL6, IL8 and sIL6R by N1L4 relative to S1L4 (control cell lines, see Methods). Figure 5A-C shows that all three ligands were expressed in N1L4 at the higher levels compared to S1L4. For IL6 at the basal level the differences between S1L4 and N1L4 were highly significant (6.9-fold increase in N1L4; p < 0.00001). For IL8 there was a 4.1-fold increase with significance p = 0.0007. For sIL6R N1L4 media was enriched by this ligand 2.4-fold compared to S1L4 with p = 0.00057. Taken together, these data show that the nu61 phenotype is associated with increased production of IL6, IL8 and sIL6R compared to the parental SCC61 cell line.
###end p 49
###begin p 50
###xml 227 234 227 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
Production of IL6 (panel A), IL8 (panel B) and sIL6R (panel C) by CV-transfected nu61 and SCC61 and cells with stable Stat1 knock-down. Cells were plated in six-well plates and 24 hours later irradiated by 3 Gy as described in Methods. Each cell line was plated in three independent wells. 48 hours conditioned media was collected and used for estimation of concentrations of IIL6, IL8 and sIL6R using ELISA kits (R & D Systems, Minneapolis, MN, USA). See text for explanations. Error bars=SE.
###end p 50
###begin p 51
###xml 165 172 165 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 250 251 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 266 275 266 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 339 340 339 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 353 362 353 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 667 676 667 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 807 808 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Next we compared differences in the production of IL6, IL8 and sIL6R in control cell lines (S1L4 and N1L4) and the corresponding Stat1 knock-downs (SKD and NKD, see Methods). Basal IL-6 production in SKD was decreased compared to the S1L4 1.97-fold (p = 0.0004; see Figure 5A). For NKD/N1L4 suppression of IL6 production was 1.3-fold with p = 0.01 (see Figure 5A). This suggests that IL-6 production is Stat1-dependent in both cell lines. For basal IL-8 production we did not detect any trends in SCC61, perhaps due to the low sub-threshold expression of this cytokine, but in nu61, we detected significant suppression of IL-8 production in NKD relative to N1L4 (see Figure 5B). NIL4 produced 8785.7 +/- 695.8 pg/ml of IL-8, while NKD produced only 6811.6 +/- 114 pg/ml. The difference was significant with p = 0.046. These data suggest that at least in N1L4 IL8 production is also associated with Stat1 expression, as is IL6 production (see above).
###end p 51
###begin p 52
###xml 94 103 94 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 378 379 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 557 558 551 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 791 800 785 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5C</xref>
###xml 1002 1003 996 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1164 1165 1158 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1453 1473 1447 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Chalaris et al. 2007</xref>
###xml 1515 1524 1509 1518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figures 2</xref>
###xml 1529 1530 1523 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">3</xref>
Finally we examined the effects of IR on the expression of IL6, IL8 and sIL6R. As is shown in Figure 5A, IL6 demonstrates clear up-regulation post IR both in SIL4 and N1L4. For S1L4 on the basal level the concentration of IL6 was equal to 78.1 + 2.92 pg/ml. 48 hours post-IR concentration increased to 220.1 +/- 8.28 pg/ml. This indicates a 2.8-fold induction with significance p = 7.95E-05. In N1L4 the basal concentration of IL6 was equal to 488.1 +/- 20.1 pg/ml. 48 hours post IR the concentration increased to 972.1 +/- 42.3 pg/ml (1.99-fold induction; p = 0.00046). These data demonstrate that IL6 production is induced by IR in both SIL4 and N1L4 cell lines. Interestingly, together with IR-induced up-regulation of IL6 in S1L4, we also detected IR-induced up-regulation of sIL6R (see Figure 5C). The basal concentration of sIL6R in S1L4 was 97.5+/-2.93 pg/ml. 48 hours post IR it increased to 126.5+/-8.4 pg/ml. The fold-induction was relatively modest (1.3-fold) but statistically significant (p = 0.0297). Contrary to these observations, in N1L4 irradiation shows a trend towards the suppression of sIL6R production (0.82-fold), but without significance (p = 0.1932). In other words, in S1L4, IR led to the up-regulation of both IL6 and sIL6R, while in N1L4, IR significantly induced only IL6 production, but not sIL6R. These data are consistent with recent observations that shedding of IL6 receptor is connected with activation of apoptosis (Chalaris et al. 2007). Sensitivity of SCC61 to apoptosis (see Figures 2 and 3) is also consistent with these data.
###end p 52
###begin p 53
###xml 22 30 22 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 686 696 686 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Discussion</italic>
The data described in Figure 5 led to three important conclusions. First, N1L4 overexpress IL6, IL8 and sIL6R on the basal level compared to the parental cell line S1L4. Pro-survival and anti-apoptotic signalling connected with these cytokines may at least in part explain the resistance of nu61 to apoptosis compared to SCC61. Second, comparing wild type (wt) and Stat1 KD variants of both cell lines we found that both IL6 and IL8 production are dependent on Stat1. To our knowledge this is the first observation that in SCC61/nu61 cell lines Stat1 expression is associated with production of IL6 and IL8. Third, we found that IL6/sIL6R system is clearly radioinducible in SCC61 (see Discussion).
###end p 53
###begin title 54
Inactivation of IL6 and IL8 sensitises cells to genotoxic stress and IFNgamma in nu61
###end title 54
###begin p 55
###xml 204 211 204 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 225 234 225 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6A</xref>
###xml 352 359 348 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 624 625 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 635 644 623 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6A</xref>
###xml 807 816 791 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
To define the role of IL6 and IL8 in nu61 survival we used neutralising antibodies to IL-8 and to IL-6 alone and in combination. Cells were treated with neutralising antibodies (N-Ab) as described in the Methods. As shown in Figure 6A, neither antibody alone affected survival of nu61 after treatment with IFNgamma alone or in combination with IR (see Methods). However, the combination of both antibodies led to a 2-fold suppression of nu61 viability after treatment with IFNgamma and a 1.9-fold suppression after combined treatment with IR and IFNgamma. The significance of these observations was confirmed by t-test with p < 0.001 (Figure 6A). We investigated the action of neutralising antibodies to IL-6 and IL-8 on the activation of apoptotic caspases-3 in response to IR and IFNgamma. As is shown in Figure 6B, neutralisation of both IL6 and IL8 led to a 4-fold increase of caspase-3-positive cells treated by the combination of IR (3 Gy) and IFNgamma (50 ng/ml).
###end p 55
###begin p 56
###xml 238 245 234 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 415 416 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1006 1007 982 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1047 1048 1023 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Cell viability of nu61 cells is reduced by neutralising antibodies to IL-6 and IL-8 and is associated with activation of apoptotic cell death. Cells were treated with either IFNgamma (50 ng/ml) alone or in combination with IR (6 Gy) (see Methods). The antibodies to IL-6 and IL-8 together, but not alone, reduced viability of nu61 in response to both IFNgamma alone and in combination with IR, with significance at p < 0.001 (panel A). Data on panel A are normalised to the cells treated by 50 ng/ml of IFNgamma, but not treated by neutralising Abs (indicated as no Ab on X-axis). Staining for active caspase-3 (panel B) shows that neutralising antibodies to IL-6 and IL-8 activate caspase-3 in response to IFNgamma + IR (representative data from three experiments). Black bars on the panel 5A represent nu61 cells treated by IFNgamma and combinations of neutralising Abs to IL6 and IL8. Grey bars represent the same cells treated by the combination of IR and IFNgamma. Error bars are standard deviations (n = 3) and asterisks indicate pairs with p values < 0.05.
###end p 56
###begin p 57
Our data indicate that treatment of parental SCC61 with recombinant IL6 and IL8 led to partial protection from IR-induced apoptosis (3 Gy) by 31.5% (not shown). Further experiments with stably transfected cell lines are necessary to fully understand the mechanisms of this protection.
###end p 57
###begin title 58
Discussion
###end title 58
###begin p 59
###xml 332 352 332 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">Khodarev et al. 2004</xref>
###xml 354 358 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">2007</xref>
###xml 703 723 703 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">Khodarev et al. 2007</xref>
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 162 171 <span type="species:ncbi:10090">nude mice</span>
In previous reports we described the selection of a human radioresistant, IFN-resistant tumour cell line, nu61, by serial passage and fractionated irradiation in nude mice. We showed that radioresistance of nu61 is associated with the constitutive up-regulation of the Stat1 pathway and Stat1-dependent, IFN-stimulated genes (ISG) (Khodarev et al. 2004, 2007). We also showed that IR can directly activate the Stat1 pathway and that selection of parental interferon/radiosensitive tumours-SCC61 against in-terferons leads to the selection of clones that are cross-resistant to IR and IFN and over-express genes in the Stat1 pathway. At the same time Stat1 knockdown leads to radiosensitisation of nu61 (Khodarev et al. 2007). These observations suggested that constitutive over-expression of the Stat1 pathway leads to combined resistance to IFN and IR, and is associated with Stat1-dependent pro-survival signalling. However, the mechanisms of this cross-resistance and pro-survival signalling remained elusive.
###end p 59
###begin p 60
###xml 92 103 92 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">Samuel 1991</xref>
###xml 342 362 342 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">Eckelman et al. 2006</xref>
###xml 364 387 364 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55">Youle and Strasser 2008</xref>
###xml 742 760 742 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">Kaplan et al. 1998</xref>
###xml 762 780 762 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">Muller et al. 2005</xref>
###xml 869 877 869 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 1072 1080 1072 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
Cytotoxicity following Stat1 activation by interferon stimulation is mediated by apoptosis (Samuel 1991). We therefore hypothesised that nu61 resistance to genotoxic stress is mediated, at least in part by resistance to apoptosis induction. Activation of the apoptosis-associated caspases is the most common hallmark of apoptotic cell death (Eckelman et al. 2006, Youle and Strasser 2008). Using various approaches for the measurement of caspases 3, 7, 8 and 9 we found that they were suppressed in nu61 relative to the SCC61. These data indicate impaired apoptotic response in nu61. This indicates that nu61 resistance to genotoxic stress is located down-stream from Stat1, contrary to the few reported cases of up-stream resistance to IFN (Kaplan et al. 1998, Muller et al. 2005). Interestingly, according to clonogenic assay, in the region of the initial slope (see Figure 1) the number of clonogenic cells in nu61 exceeds that in SCC61 by approximately two-fold. This is the inverse of the proportion of caspase-3 positive apoptotic cells in the short-term assay (see Figure 2). This suggests that decreased apoptosis in nu61 may be connected with increased proportion of apoptosis-resistant clonogenic cells in nu61 population, which is consistent with our results about increased production of growth/proliferation-stimulating cytokines in nu61 (see below).
###end p 60
###begin p 61
###xml 252 275 252 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49">Varfolomeev et al. 2005</xref>
###xml 277 292 277 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">Dai et al. 2006</xref>
###xml 294 314 294 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">Baritaki et al. 2007</xref>
###xml 533 557 529 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b53">Weichselbaum et al. 2002</xref>
###xml 559 574 555 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">Han et al. 2008</xref>
###xml 783 799 779 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">Dunn et al. 2005</xref>
We further suggested that suppression of apoptotic cell death in nu61 might lead to the increased resistance of this cell line and corresponding tumours to the death ligands of the TNFR superfamily, which mostly operate through induction of apoptosis (Varfolomeev et al. 2005, Dai et al. 2006, Baritaki et al. 2007). Indeed, our results show that in addition to IR and IFN resistance, nu61 relative to SCC61 is also resistant to TNFalpha, TRAIL and FAS. All of these ligands are known to be involved in the control of tumour growth (Weichselbaum et al. 2002, Han et al. 2008). It is possible that the selection of radioresistant tumour clones induced by fractionated irradiation is associated with suppression of apoptotic pathways activated by different pro-inflammatory cytokines (Dunn et al. 2005).
###end p 61
###begin p 62
###xml 140 160 140 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">Khodarev et al. 2007</xref>
###xml 162 186 162 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">Weichselbaum et al. 2008</xref>
###xml 311 322 311 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">Samuel 2001</xref>
###xml 324 345 324 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">Levy and Darnell 2002</xref>
Our previous data also indicated that in nu61 the functions of Stat1 are connected with pro-survival and radio/chemo-protective signalling (Khodarev et al. 2007, Weichselbaum et al. 2008). We should note that these observations are contradictory to traditional understanding of Stat1 as tumour suppressor gene (Samuel 2001, Levy and Darnell 2002). However, currently several laboratories have confirmed the association of Stat1 with an aggressive chemo-/radio-resistant and oncogenic phenotype.
###end p 62
###begin p 63
###xml 112 133 112 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47">Timofeeva et al. 2006</xref>
###xml 192 208 192 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">Kita et al. 2003</xref>
###xml 261 280 261 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">Steiner et al. 2006</xref>
###xml 453 474 453 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">Friedberg et al. 2004</xref>
###xml 490 508 490 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46">Thomas et al. 2004</xref>
###xml 525 544 525 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">Roberts et al. 2005</xref>
###xml 605 627 605 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">Rickardson et al. 2005</xref>
###xml 629 648 629 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">Fryknas et al. 2007</xref>
###xml 764 779 764 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">Hui et al. 2009</xref>
###xml 834 854 834 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">Khodarev et al. 2007</xref>
###xml 1125 1144 1125 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">Adams and Cory 2002</xref>
###xml 1146 1167 1146 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">Tan and Coussens 2007</xref>
###xml 1244 1252 1244 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 1484 1492 1484 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 1573 1597 1573 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">Bachelor and Bowden 2004</xref>
###xml 1599 1616 1599 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">Hodge et al. 2005</xref>
###xml 1618 1638 1618 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Nicolini et al. 2006</xref>
###xml 1819 1841 1819 1841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">Ernst and Jenkins 2004</xref>
###xml 1843 1862 1843 1862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54">Yamaoka et al. 2004</xref>
###xml 1864 1884 1864 1884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">Hu and Nicholas 2006</xref>
###xml 1886 1906 1886 1906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">Galdiero et al. 2006</xref>
###xml 2009 2017 2009 2017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
It has been shown that Stat1 can control essential pro-survival genes, such as Myeloid Cell Leukemia 1 (MCL-1) (Timofeeva et al. 2006), Interferon-Induci-ble Transmembrane Protein 1 (IFITM1) (Kita et al. 2003) and multi-drug resistance Major Vault Protein MVP (Steiner et al. 2006). Constitutive over-expression of Stat1 and Stat1-dependent genes is associated with protection of tumour cells from genotoxic stress following treatment with fludarabine (Friedberg et al. 2004), doxorubicin (Thomas et al. 2004), cis-platinum (Roberts et al. 2005) and the combination of ionising radiation and doxorubicin (Rickardson et al. 2005, Fryknas et al. 2007). Most recently it was demonstrated that suppression of Stat1 leads to radiosensitisation in renal cell carcinoma (Hui et al. 2009), which is consistent with our previous observations (Khodarev et al. 2007). In the current report we provide a partial mechanistic explanation for such a 'reversed' Stat1-dependent phenotype that is connected with alterations in apoptosis. Another part of an explanation may be connected with secretion of Stat1-dependent pro-survival factors (Adams and Cory 2002, Tan and Coussens 2007). To test this hypothesis we established co-cultures of nu61 and SCC61 (see Figure 4) and found that nu61 secretes factors which partially rescue SCC61 from cell death. We identified these factors as IL8, IL6 and the soluble receptor of IL6 (sIL6R), which were differentially secreted by nu61 compared to SCC61 (see Figure 5). IL6 and IL8 signalling are recognised as important factors of tumourogenesis (Bachelor and Bowden 2004, Hodge et al. 2005, Nicolini et al. 2006) and may be associated with the Stat1 pathway through glycoprotein 130 (gp130), CCAAT/enhancer binding protein beta (C/EBP beta) and direct interaction of Stat1 with IL8 promoter (Ernst and Jenkins 2004, Yamaoka et al. 2004, Hu and Nicholas 2006, Galdiero et al. 2006). Our experiments show that expression of IL6 and IL8 is directly suppressed by Stat1 knock-down (see Figure 5). These experiments suggest that expression of these cytokines is controlled by Stat1, but additional experiments are needed to decode these relationships.
###end p 63
###begin p 64
###xml 271 293 271 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">Ernst and Jenkins 2004</xref>
###xml 422 442 422 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Chalaris et al. 2007</xref>
###xml 506 514 506 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 519 527 519 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
Of specific interest are our observations about sIL6R. This receptor does not individually activate down-stream signalling. Upon binding with IL6 it further binds to the ubiquitous receptor gp130, and activates Stat1/Stat3 pathways and pro-survival Ras and Akt pathways (Ernst and Jenkins 2004). These processes called 'trans-signalling' and solubilisation (shedding) of sIL6R are associated with activation of apoptosis (Chalaris et al. 2007). These data are consistent with our observations presented in Figure 4 and Figure 5 and suggest that nu61 cells may not only promote their own growth and survival but also form pro-survival paracrine loops, at least in part involving IL8/IL6/sIL6R network.
###end p 64
###begin p 65
###xml 106 114 106 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
Our experiments show that this phenotype can be reversed with neutralising antibodies to IL6 and IL8 (see Figure 6). These results provide compelling evidence that IL6-IL8 signalling is associated with resistant phenotype of nu61.
###end p 65
###begin p 66
###xml 333 354 329 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">Nishigaki et al. 2006</xref>
###xml 356 373 352 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">Buess et al. 2007</xref>
###xml 375 395 371 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">Andersen et al. 2008</xref>
###xml 575 583 571 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
Based on our results we hypothesise that Stat1, IL6/sIL6Ralpha and IL8 form an interdependent network associated with increased survival of nu61. The parental tumour clone (SCC61) is subjected to negative pressure from irradiation and/or the tumour microenvironment which produce multiple factors able to activate the Stat1 pathway (Nishigaki et al. 2006, Buess et al. 2007, Andersen et al. 2008). Importantly, our data suggest that IR-induced up-regulation of IL6 in parental SCC61 tumour cells might be one of the initial events in the activation of the Stat1 pathway (see Figure 5). This activation leads to the elimination of the majority of the tumour cells, sensitive to Stat1-delivered cytotoxicity but also induces the selection of 'nu61-like' clones, which are resistant to irradiation and the stromal death ligands due to suppression of Stat1-dependent apoptotic pathways. The ability of these cells to secrete pro-survival ligands promotes growth and the transformation of surrounding less aggressive tumour or pre-malignant clones. This selection leads to the formation of tumour clones with aggressive properties and combined resistance to IR, chemotherapy and cytotoxic cytokines.
###end p 66
###begin p 67
Our previous and current data suggest that targeting Stat1, IL6 and IL8 may enhance the therapeutic ratio for treatment of Stat1 over-expressing tumours.
###end p 67
###begin p 68
This work was supported by NIH grants PO1-CA71933 (R.R.W. and B.R), RO1-CA113662 and R01 CA111423 (R.R.W). The authors are grateful to Dr H. Mauceri for discussion and help in preparation of this manuscript.
###end p 68
###begin title 69
Declaration of interest
###end title 69
###begin p 70
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
Apoptosomes: Engines for caspase activation
###end article-title 72
###begin article-title 73
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
Human in vivo radiation-induced biomarkers: Gene expression changes in radiotherapy patients
###end article-title 73
###begin article-title 74
###xml 92 97 <span type="species:ncbi:9606">human</span>
EGFR induces expression of IRF-1 via STAT1 and STAT3 activation leading to growth arrest of human cancer cells
###end article-title 74
###begin article-title 75
UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression
###end article-title 75
###begin article-title 76
Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation
###end article-title 76
###begin article-title 77
###xml 60 61 60 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 62 63 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Poly(ADP-ribose) glycohydrolase silencing protects against H2O2-induced cell death
###end article-title 77
###begin article-title 78
Glioblastoma cells block radiation-induced programmed cell death of endothelial cells
###end article-title 78
###begin article-title 79
Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer
###end article-title 79
###begin article-title 80
Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils
###end article-title 80
###begin article-title 81
Molecular correlates of site-specific metastasis
###end article-title 81
###begin article-title 82
Interferon-gamma and cancer immunoediting
###end article-title 82
###begin article-title 83
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 61 66 <span type="species:ncbi:9940">sheep</span>
Human inhibitor of apoptosis proteins: Why XIAP is the black sheep of the family
###end article-title 83
###begin article-title 84
Acquiring signalling specificity from the cytokine receptor gp130
###end article-title 84
###begin article-title 85
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo
###end article-title 85
###begin article-title 86
STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines
###end article-title 86
###begin article-title 87
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
###end article-title 87
###begin article-title 88
Structural requirements for proinflammatory activity of porin P2 Loop 7 from Haemophi-lus influenzae
###end article-title 88
###begin article-title 89
Involvement of protective autophagy in TRAIL-resistance of apoptosis defective tumor cells
###end article-title 89
###begin article-title 90
Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed
###end article-title 90
###begin article-title 91
The role of IL-6 and STAT3 in inflammation and cancer
###end article-title 91
###begin article-title 92
###xml 23 42 <span type="species:ncbi:37296">human herpesvirus 8</span>
###xml 188 193 <span type="species:ncbi:9606">human</span>
Signal transduction by human herpesvirus 8 viral interleukin-6 (vIL-6) is modulated by the nonsignaling gp80 subunit of the IL-6 receptor complex and is distinct from signaling induced by human IL-6
###end article-title 92
###begin article-title 93
Radiosensitization by inhibiting STAT1 in renal cell carcinoma
###end article-title 93
###begin article-title 94
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Demonstratiof an interferon gamma-dependent tumor surveillance system in immunocom-petent mice
###end article-title 94
###begin article-title 95
STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells
###end article-title 95
###begin article-title 96
Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells
###end article-title 96
###begin article-title 97
Dose-dependent and independent temporal patterns of gene responses to ionizing radiation in normal and tumor cells and tumor xenografts
###end article-title 97
###begin article-title 98
Recent advances in understanding the cell death pathways activated by anticancer therapy
###end article-title 98
###begin article-title 99
###xml 62 67 <span type="species:ncbi:9606">human</span>
Involvement of LEU 13 in interferon-induced refractoriness of human RSa cells to cell killing by X-rays
###end article-title 99
###begin article-title 100
p53 mutations increase resistance to ionizing radiation
###end article-title 100
###begin article-title 101
Changes in host defence induced by malignancies and antineoplastic treatment: Implication for immunotherapeutic strategies
###end article-title 101
###begin article-title 102
###xml 27 32 <span type="species:ncbi:9606">human</span>
Chemotherapeutic drugs and human tumor cells cytokine network
###end article-title 102
###begin article-title 103
Stats Transcriptional control and biological impact
###end article-title 103
###begin article-title 104
Identification of JAK/STAT signalling components by genome-wide RNA interference
###end article-title 104
###begin article-title 105
Cytokines in breast cancer
###end article-title 105
###begin article-title 106
###xml 35 68 <span type="species:ncbi:11820">friend spleen focus-forming virus</span>
Erythroblast transformation by the friend spleen focus-forming virus is associated with a block in erythropoietin-induced STAT1 phosphorylation and DNA binding and correlates with high expression of the hematopoietic phosphatase SHP-1
###end article-title 106
###begin article-title 107
Cutting edge: Inherent and acquired resistance to radiation-induced apopto-sis in B cells. A pivotal role for STAT3
###end article-title 107
###begin article-title 108
###xml 64 69 <span type="species:ncbi:9606">human</span>
Variation in radiation sensitivity during the cell cycle of two human squamous cell carcinomas
###end article-title 108
###begin article-title 109
Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles
###end article-title 109
###begin article-title 110
###xml 84 89 <span type="species:ncbi:9606">human</span>
Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells
###end article-title 110
###begin article-title 111
NM-3 an isocoumarin increases the antitumor effects of radiotherapy without toxicity
###end article-title 111
###begin article-title 112
Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities
###end article-title 112
###begin article-title 113
Antiviral actions of interferons
###end article-title 113
###begin article-title 114
The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals
###end article-title 114
###begin article-title 115
Humoral immunity inflammation and cancer
###end article-title 115
###begin article-title 116
STAT1: A modulator of chemotherapy-induced apoptosis
###end article-title 116
###begin article-title 117
Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis
###end article-title 117
###begin article-title 118
Isolation and characterization of highly radioresistant malignant hamster fibroblasts that survive acute gamma irradiation with 20 Gy
###end article-title 118
###begin article-title 119
Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand
###end article-title 119
###begin article-title 120
In vitro determination of radiation sensitivity parameters for DU-145 prostate cancer cells
###end article-title 120
###begin article-title 121
###xml 34 39 <span type="species:ncbi:9606">human</span>
The maximum recovery potential of human tumor cells may predict clinical outcome in radiotherapy
###end article-title 121
###begin article-title 122
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breastcancer
###end article-title 122
###begin article-title 123
Radiation-induced tumour necrosis factor-alpha expression: Clinical application of transcriptional and physical targeting of gene therapy
###end article-title 123
###begin article-title 124
###xml 92 111 92 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 92 111 <span type="species:ncbi:210">Helicobacter pylori</span>
Role of interferon-stimulated res-ponsive element-like element in interleukin-8 promoter in Helicobacter pylori infection
###end article-title 124
###begin article-title 125
The BCL-2 protein family: Opposing activities that mediate cell death
###end article-title 125

